News

A case report highlights a 51-year-old man with stage IV non-small cell lung cancer and brain metastasis who received whole brain radiotherapy followed by immune checkpoint inhibitor treatment.

Researchers reveal that RTP801, a protein elevated in Alzheimer’s patients, disrupts RNA processing and protein synthesis, exacerbating cognitive decline. This discovery could lead to new therapeutic strategies.

Researchers have mapped the genetic landscape of cancer drug resistance, uncovering that DNA changes can be grouped into four main categories and highlighting possible new therapeutic targets.

New research shows microbes in our cities are evolving to resist the very cleaners we use to eliminate them. It also identifies novel strains living in Hong Kong that were previously only found in Antarctic desert soil.

Using MRI scans, a new study has found that neural responses to different types of fears activated different brain areas, rather than following a single pattern.

An international team of neuroscientists showed for the first time that modifying a protein that controls cell growth can reactivate dormant neural stem cells in fruit flies, offering new hope in the fight against neurological diseases.

A study from Johns Hopkins Medicine reveals that men with low-risk prostate cancer may reduce their progression risk by adhering to a healthy diet. Higher scores on the Healthy Eating Index correlated with lower rates of grade reclassification.

Researchers have developed an AI model, “EUCAST-GPT-expert,” using GPT-4 to analyze antibiotic resistance through the Kirby-Bauer disk diffusion test. While the AI tool aids in identifying resistance, it is not as accurate as human experts.

A new study offers fresh insights into our understanding of colorectal cancer, challenging the conventional right- and left-sided disease classifications.

The first randomized clinical trial on monoclonal antibodies' impact on long COVID found that the combination of amubarvimab and romlusevimab did not decrease long COVID symptoms.